These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37543511)

  • 21. Discriminative Capacity of CT Volumetry to Identify Autonomous Cortisol Secretion in Incidental Adrenal Adenomas.
    Olmos R; Mertens N; Vaidya A; Uslar T; Fernandez P; Guarda FJ; Zúñiga Á; San Francisco I; Huete A; Baudrand R
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1946-e1953. PubMed ID: 35020922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas.
    Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2021 Dec; 20(4):735-744. PubMed ID: 34273083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive model for autonomous cortisol secretion development in non-functioning adrenal incidentalomas.
    Araujo-Castro M; García Cano AM; Escobar-Morreale HF; Valderrabano P
    Hormones (Athens); 2023 Mar; 22(1):51-59. PubMed ID: 36279032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.
    Di Dalmazi G; Vicennati V; Pizzi C; Mosconi C; Tucci L; Balacchi C; Cosentino ER; Paolisso P; Fanelli F; Gambineri A; Pelusi C; Repaci A; Garelli S; Galiè N; Borghi C; Golfieri R; Pagotto U
    J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32413902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of Adrenal Cortical Adenomas: Assessment of Bone Status in Patients with (Non-Functioning) Adrenal Incidentalomas.
    Trandafir AI; Stanciu M; Albu SE; Stoian VR; Ciofu I; Persu C; Nistor C; Carsote M
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autonomous cortisol secretion in adrenal incidentalomas.
    Araujo-Castro M; Sampedro Núñez MA; Marazuela M
    Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
    Tsilchorozidou T; Honour JW; Conway GS
    J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
    Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
    Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted LC-MS/MS analysis of steroid glucuronides in human urine.
    Wang R; Hartmann MF; Wudy SA
    J Steroid Biochem Mol Biol; 2021 Jan; 205():105774. PubMed ID: 33172831
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and incidence of type 2 diabetes mellitus in patients with adrenal incidentalomas: a study of 709 cases.
    Brox-Torrecilla N; García Cano AM; Valderrábano P; Quintero Tobar A; Escobar-Morreale HF; Araujo-Castro M
    Endocrine; 2023 Sep; 81(3):484-491. PubMed ID: 37212980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Performance of DHEAS as a Screening Test for Autonomous Cortisol Secretion in Adrenal Incidentalomas: A Prospective Study.
    Liu MS; Lou Y; Chen H; Wang YJ; Zhang ZW; Li P; Zhu DL
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1789-e1796. PubMed ID: 35137142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delineating endogenous Cushing's syndrome by GC-MS urinary steroid metabotyping.
    Braun LT; Osswald A; Zopp S; Rubinstein G; Vogel F; Riester A; Honegger J; Eisenhofer G; Constantinescu G; Deutschbein T; Quinkler M; Elbelt U; Künzel H; Nowotny HF; Reisch N; Hartmann MF; Beuschlein F; Pons-Kühnemann J; Reincke M; Wudy SA
    EBioMedicine; 2024 Jan; 99():104907. PubMed ID: 38128413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum levels of dehydroepiandrosterone sulfate in patients with asymptomatic cortisol producing adrenal adenoma: comparison with adrenal Cushing's syndrome and non-functional adrenal tumor.
    Morio H; Terano T; Yamamoto K; Tomizuka T; Oeda T; Saito Y; Tamura Y; Sasano H
    Endocr J; 1996 Aug; 43(4):387-96. PubMed ID: 8930526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pros and cons of dexamethasone suppression test for screening of subclinical Cushing's syndrome in patients with adrenal incidentalomas.
    Reimondo G; Allasino B; Bovio S; Saba L; Ardito A; Angeli A; Terzolo M
    J Endocrinol Invest; 2011 Jan; 34(1):e1-5. PubMed ID: 20634637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
    Eller-Vainicher C; Morelli V; Ulivieri FM; Palmieri S; Zhukouskaya VV; Cairoli E; Pino R; Naccarato A; Scillitani A; Beck-Peccoz P; Chiodini I
    J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome.
    Vogg N; Kurlbaum M; Deutschbein T; Gräsl B; Fassnacht M; Kroiss M
    Clin Chem; 2021 Jul; 67(7):998-1007. PubMed ID: 33997885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mild autonomous cortisol secretion in adrenal incidentalomas and risk of fragility fractures: a large cross-sectional study.
    Zavatta G; Vicennati V; Altieri P; Tucci L; Colombin G; Coscia K; Mosconi C; Balacchi C; Fanelli F; Malagrinò M; Magagnoli M; Golfieri R; Pagotto U; Di Dalmazi G
    Eur J Endocrinol; 2023 Apr; 188(4):343-352. PubMed ID: 36952249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The diagnostic value of salivary cortisol and salivary cortisone in patients with suspected hypercortisolism.
    Berndt V; Dahlqvist P; de Verdier J; Ryberg H; Ragnarsson O
    Front Endocrinol (Lausanne); 2022; 13():1028804. PubMed ID: 36506050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adrenalectomy improves blood pressure control in nonfunctioning adrenal incidentalomas and glycemic and lipid control in patients with autonomous cortisol secretion.
    Araujo-Castro M; Mínguez Ojeda C; Sánchez Ramírez MN; Gómez Dos Santos V; Pascual-Corrrales E; Fernández-Argüeso M
    Endocrine; 2022 Oct; 78(1):142-150. PubMed ID: 35751779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiometabolic Disease Burden and Steroid Excretion in Benign Adrenal Tumors : A Cross-Sectional Multicenter Study.
    Prete A; Subramanian A; Bancos I; Chortis V; Tsagarakis S; Lang K; Macech M; Delivanis DA; Pupovac ID; Reimondo G; Marina LV; Deutschbein T; Balomenaki M; O'Reilly MW; Gilligan LC; Jenkinson C; Bednarczuk T; Zhang CD; Dusek T; Diamantopoulos A; Asia M; Kondracka A; Li D; Masjkur JR; Quinkler M; Ueland GÅ; Dennedy MC; Beuschlein F; Tabarin A; Fassnacht M; Ivović M; Terzolo M; Kastelan D; Young WF; Manolopoulos KN; Ambroziak U; Vassiliadi DA; Taylor AE; Sitch AJ; Nirantharakumar K; Arlt W; ;
    Ann Intern Med; 2022 Mar; 175(3):325-334. PubMed ID: 34978855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.